General Information of This Antigen (ID: TAR0LXDND)
Antigen Name
Lymphocyte antigen 6E (LY6E)
Gene Name
LY6E
Gene ID
4061
Synonym
Retinoic acid-induced gene E protein;Stem cell antigen 2;Thymic shared antigen 1
Sequence
MKIFLPVLLAALLGVERASSLMCFSCLNQKSNLYCLKPTICSDQDNYCVTVSASAGIGNL
VTFGHSLSKTCSPACPIPEGVNVGVASMGISCCQSFLCNFSAADGGLRASVTLLGAGLLL
SLLPALLRFGP

    Click to Show/Hide
Function
GPI-anchored cell surface protein that regulates T- lymphocytes proliferation, differentiation, and activation. Regulates the T-cell receptor (TCR) signaling by interacting with component CD3Z/CD247 at the plasma membrane, leading to CD3Z/CD247 phosphorylation modulation. Restricts the entry of human coronaviruses, including SARS-CoV, MERS-CoV and SARS-CoV-2, by interfering with spike protein-mediated membrane fusion. Also plays an essential role in placenta formation by acting as the main receptor for syncytin-A (SynA). Therefore, participates in the normal fusion of syncytiotrophoblast layer I (SynT- I) and in the proper morphogenesis of both fetal and maternal vasculatures within the placenta. May also act as a modulator of nicotinic acetylcholine receptors (nAChRs) activity.

    Click to Show/Hide
Uniprot Entry
LY6E_HUMAN
HGNC ID
HGNC:6727
KEGG ID
hsa:4061
Each Antibody-drug Conjugate and Its Component Related to This Antigen
Full List of The ADC Related to This Antigen
The Numbers of ADCs, Their Three Components, Payload Targets, and Corresponding Diseases for This Antigens
Anti-gD-LC-K149C
ADC Name Payload Target Linker ADC Info
Alpha-gD-LC-K149C-10 [1]
seco-CBI-dimer
Human Deoxyribonucleic acid (hDNA)
Mc-peptidomimetic based linker 10
Anti-Ly6E antibody
ADC Name Payload Target Linker ADC Info
M7437
Exatecan
DNA topoisomerase 1 (TOP1)
Undisclosed
Anti-Ly6E-LC-K149C
ADC Name Payload Target Linker ADC Info
Alpha-Ly6E-LC-K149C-11 [1]
seco-CBI-dimer
Human Deoxyribonucleic acid (hDNA)
Mal-PEG2
MLYE4489A
ADC Name Payload Target Linker ADC Info
RG7841
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Thio hu Anti-Ly6E 9B12.v12 LC K149C
ADC Name Payload Target Linker ADC Info
WO2016205176A1 ADC-101 [2]
WO2016205176A1_ADC-101 payload
Undisclosed
WO2016205176A1_ADC-101 linker
WO2016205176A1 ADC-102 [2]
WO2016205176A1_ADC-102 payload
Undisclosed
WO2016205176A1_ADC-102 linker
WO2016205176A1 ADC-103 [2]
WO2016205176A1_ADC-103 payload
Undisclosed
WO2016205176A1_ADC-103 linker
WO2017059289A1 ADC-115 [3]
WO2017059289A1_ADC-115 payload
Undisclosed
WO2017059289A1_ADC-115 linker
WO2017059289A1 ADC-210 [3]
WO2017059289A1_ADC-210 payload
Undisclosed
WO2017059289A1_ADC-210 linker
WO2017214024A1 ADC-107 [4]
WO2017214024A1_ADC-107 payload
Undisclosed
WO2017214024A1_ADC-107 linker
WO2017214024A1 ADC-109 [4]
WO2017214024A1_ADC-109 payload
Undisclosed
WO2017214024A1_ADC-109 linker
Thio hu Anti-Ly6E LC K149C
ADC Name Payload Target Linker ADC Info
WO2017059289A1 ADC-212 [3]
WO2017059289A1_ADC-212 payload
Undisclosed
WO2017059289A1_ADC-212 linker
Undisclosed
ADC Name Payload Target Linker ADC Info
ZW327 [5]
Undisclosed
Undisclosed
Mc-Gly-Gly-Phe-Gly
References
Ref 1 Antibody-Drug Conjugates Derived from Cytotoxic seco-CBI-Dimer Payloads Are Highly Efficacious in Xenograft Models and Form Protein Adducts In Vivo. Bioconjug Chem. 2019 May 15;30(5):1356-1370. doi: 10.1021/acs.bioconjchem.9b00133. Epub 2019 Apr 22.
Ref 2 Antibodies and immunoconjugates; 2016-12-22.
Ref 3 Pyrrolobenzodiazepine antibody drug conjugates and methods of use; 2017-04-06.
Ref 4 Silvestrol antibody-drug conjugates and methods of use; 2017-12-14.
Ref 5 ZW327, a novel Ly6E-targeting antibody-drug conjugate bearing a topoisomerase 1 inhibitor payload